Inhibitor

(redirected from Alpha-glucosidase inhibitor)
Also found in: Dictionary, Thesaurus, Medical, Legal, Wikipedia.
Related to Alpha-glucosidase inhibitor: thiazolidinedione

inhibitor

[in′hib·əd·ər]
(aerospace engineering)
A substance bonded, taped, or dip-dried onto a solid propellant to restrict the burning surface and to give direction to the burning process.
(chemistry)
A substance which is capable of stopping or retarding a chemical reaction; to be technically useful, it must be effective in low concentration.

Inhibitor

 

a circuit having m + n inputs and a single output, at which a signal can appear only when there are no signals on the m inputs (inhibiting). The other n inputs (principal) form one of the two logic connections, “AND” or “OR.” Inhibitors are used extensively in computers. They are very often understood to be a circuit having a single principal input and a single inhibiting input. A signal appears at the output of such a circuit when a signal is present on the principal input but there is none on the inhibiting input. Such an inhibitor is called an anticoincidence gate; its conventional representation is given in Figure 1.

Figure 1. Block diagram of an anticoincidence gate (inhibitor) with m — 1 and n 1:(A) principal input, (Q) inhibiting input, (Ga) anticoincidence gate

inhibitor

A substance added to paint to retard drying, skinning, mildew growth, etc. Also see corrosion inhibitor, inhibiting pigment, drying inhibitor.
References in periodicals archive ?
In contrast to sulfonylureas and biguanides, alpha-glucosidase inhibitors do not lower fasting glucose levels.
TABLE 1 How these antidiabetic drugs affect weight (3) Weight gain Weight neutral Weight loss Insulin Alpha-glucosidase inhibitors GLP-1 agonists Meglitinides Bromocriptine Metformin Sulfonylureas Colesevelam Pramlintide Thiazolidinediones DPP-4 inhibitors SGLT2 inhibitors DPP-4, dipeptidyl peptidase-4; GLP-1, glucagon-like peptide-1; SGLT2, sodium-glucose co-transporter 2.
Alpha-glucosidase inhibitors (miglitol, Glyset[R]; ascarbose, Precose[R]) produce their glucose lowering effect by slowing the absorption of carbohydrate from the upper gastrointestinal (GI) tract.
known hypersensitivity to the particular alpha-glucosidase inhibitors, or components of their formulations.
Possible combinations with sulfonylurea drugs, alpha-glucosidase inhibitors and biguanide drugs can be foreseen.
Alpha-glucosidase inhibitors (AL-fa gloo-KOS-ih-dayss in-HIB-it-ers).
According to the metabolic fulcrum-based, strategy, insulin and insulin secretagogues are preferred in patients with predominant insulin deficiency (catabolism), dipeptidyl peptidase 4 inhibitors (DPP4i) and alpha-glucosidase inhibitors (AGIs) find utility in eubolic type 2 diabetes, while glucagon- like peptide 1 receptor agonists (GLP1RA) and sodium glucose cotransporter 2 inhibitors (SGLT2i) are strongly indicated in those with predominant insulin resistance (maladaptive anabolism).
Alpha-glucosidase inhibitors for people with impaired glucose tolerance or impaired fasting blood glucose.
Available oral agents include insulinotropic agents (sulfonylureas and meglitinides), biguanides, alpha-glucosidase inhibitors, and thiazolidinediones (glitazones).
According to the National Diabetes Information Clearinghouse (a federal agency), five major classes of diabetes drugs are on the market: sulfonylureas, biguanides, alpha-glucosidase inhibitors, thiazolidinediones and meglitinides.
Find Your Diabetes Medicines(*) Sulfonylureas Amaryl DiaBeta Diabinese Dymelor Glucotrol Glucotrol XL Glynase PresTab Micronase Orinase Tolinase Biguanides Glucophage Alpha-glucosidase Inhibitors Glyset Precose Thiazolidinediones Rezulin Meglitinides: Prandin Insulins Lispro (Humalog) Regular Premixed Ultralente NPH or Lente
7 However, they, along with sodium glucose co-transporter (SGLT) 2 inhibitors, pioglitazone and alpha-glucosidase inhibitors, are able to reduce blood pressure significantly.